| Database ID | Agent | Target | Cancer Type | Detail |
| DB00391 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00392 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00393 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00394 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00395 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00396 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00397 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00398 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00399 | erlotinib | Epidermal growth factor receptor | head and neck cancer | view |
| DB00400 | SU5416 | Vascular endothelial growth factor | head and neck cancer | view |
| DB00401 | erlotinib | Epidermal growth factor receptor | esophageal cancer | view |
| DB00402 | erlotinib | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00403 | erlotinib | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |
| DB00404 | erlotinib | Epidermal growth factor receptor | esophageal cancer | view |
| DB00405 | erlotinib | Epidermal growth factor receptor | esophagusgastroesophageal junction cancer | view |